The present findings suggest HSD17B13 rs72613567:TA allelic variant can reduce the risk of hepatocellular carcinoma and NAFLD in the entire population studied. The gene discussed is HSD17B13; the disease is metabolic dysfunction-associated steatotic liver disease.